Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine infiltration with dexamethasone or dexmedetomidine for postoperative pain in unilateral cleft lip surgery
IRCT20220312054261N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative pain comparing Bupivacaine + epinephrine + dexamethasone, Bupivacaine + epinephrine + dexmedetomidine and Bupivacaine + epinephrine control (3 arms). Primary endpoint: Pain. Started May 2022; status: completed.
02
Drugs
bupivacainedexamethasonedexmedetomidineepinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20220312054261N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220312054261N1.